{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:36:07Z","timestamp":1791045367740,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Patients with mean pulmonary artery pressures (mPAP) of 21 to 24\u00a0mm Hg have a so-called borderline elevation of mPAP (BoPAP)\u2014a condition thought to represent early-stage pulmonary arterial vasculopathy. Based on the DETECT study, this post-hoc analysis examined patient characteristics of systemic sclerosis (SSc) patients with normal mPAP, BoPAP and elevated mPAP, fulfilling pulmonary arterial hypertension (PAH) criteria.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>Adult patients with a duration of SSc more than 3\u00a0years, a diffusing capacity of the lung for carbon monoxide less than 60% predicted, and no previous diagnosis of any form of pulmonary hypertension (PH) underwent screening tests followed by right heart catheterization. Subjects were divided into three groups: normal mPAP, BoPAP, and PAH. Exploratory comparative and binary logistic regression analyses were performed for the BoPAP versus normal mPAP and PAH versus BoPAP groups.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Of 244 patients evaluated, 148 (60%) had normal mPAP, 36 (15%) had BoPAP<jats:bold>,<\/jats:bold> and 60 (25%) had definite PAH. Univariable logistic regression (ULR) showed the mean tricuspid regurgitation velocity in patients with BoPAP to be intermediate between normal mPAP and PAH. In the ULR analyses BoPAP versus normal mPAP and PAH versus BoPAP, the statistically significant predictors were, amongst others: demographic, clinical, pulmonary function, echocardiographic and hemodynamic variables.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>In this exploratory post-hoc analysis of the DETECT study population patients with BoPAP could be distinguished from patients with normal mPAP and PAH, and it appears that BoPAP may be an intermediate stage on the continuum between normal PA pressures and PAH.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/s13075-014-0493-1","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T12:25:29Z","timestamp":1418127929000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study"],"prefix":"10.1186","volume":"16","author":[{"given":"Scott H","family":"Visovatti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Distler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Gerry","family":"Coghlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P","family":"Denton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Gr\u00fcnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Bonderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E","family":"Pope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon C","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R","family":"Seibold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Vicente","family":"Torres-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Doelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harbajan","family":"Chadha-Boreham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vallerie V","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"493_CR1","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA: Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis. 2007, 66: 940-944. 10.1136\/ard.2006.066068.","journal-title":"Ann Rheum Dis"},{"key":"493_CR2","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1136\/ard.2009.114264","volume":"69","author":"AJ Tyndall","year":"2010","unstructured":"Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, Bancel DF, Allanore Y, Muller-Ladner U, Distler O, Iannone F, Pellerito R, Pileckyte M, Miniati I, Ananieva L, Gurman AB, Damjanov N, Mueller A, Valentini G, Riemekasten G, Tikly M, Hummers L, Henriques MJ, Caramaschi P, Scheja A, Rozman B, Ton E, Kum\u00e1novics G, Coleiro B, Feierl E: Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis. 2010, 69: 1809-1815. 10.1136\/ard.2009.114264.","journal-title":"Ann Rheum Dis"},{"key":"493_CR3","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/art.1780290409","volume":"29","author":"AM Stupi","year":"1986","unstructured":"Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA: Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 1986, 29: 515-524. 10.1002\/art.1780290409.","journal-title":"Arthritis Rheum"},{"key":"493_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1164\/rccm.200806-953OC","volume":"179","author":"R Condliffe","year":"2009","unstructured":"Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, Das C, Elliot CA, Johnson M, DeSoyza J, Torpy C, Goldsmith K, Hodgkins D, Hughes RJ, Pepke-Zaba J, Coghlan JG: Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med. 2009, 179: 151-157. 10.1164\/rccm.200806-953OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"493_CR5","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1164\/rccm.200204-333OC","volume":"167","author":"KP Kuhn","year":"2003","unstructured":"Kuhn KP, Byrne DW, Arbogast PG, Doyle TP, Loyd JE, Robbins IM: Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenol. Am J Respir Crit Care Med. 2003, 167: 580-586. 10.1164\/rccm.200204-333OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"493_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1136\/annrheumdis-2011-200265","volume":"71","author":"PJ Clements","year":"2012","unstructured":"Clements PJ, Tan M, McLaughlin VV, Oudiz RJ, Tapson VF, Channick RN, Rubin LJ, Langer A: The pulmonary arterial hypertension quality enhancement research initiative: comparison of patients with idiopathic PAH to patients with systemic sclerosis-associated PAH. Ann Rheum Dis. 2012, 71: 249-252. 10.1136\/annrheumdis-2011-200265.","journal-title":"Ann Rheum Dis"},{"key":"493_CR7","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1378\/chest.12-0653","volume":"144","author":"M Rubenfire","year":"2013","unstructured":"Rubenfire M, Huffman M, Krishnan S, Seibold JR, Schiopu E, McLaughlin VV: Survival in systemic sclerosis with pulmonary arterial hypertension has not improved in the modern era. Chest. 2013, 144: 1282-10.1378\/chest.12-0653.","journal-title":"Chest"},{"key":"493_CR8","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1002\/art.30541","volume":"63","author":"M Humbert","year":"2011","unstructured":"Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, Gressin V, Guillevin L, Clerson P, Simonneau G, Hachulla E: Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival. Arthritis Rheum. 2011, 63: 3522-3530. 10.1002\/art.30541.","journal-title":"Arthritis Rheum"},{"key":"493_CR9","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J: ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009, 53: 1573-1619. 10.1016\/j.jacc.2009.01.004.","journal-title":"J Am Coll Cardiol"},{"key":"493_CR10","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1002\/art.38172","volume":"65","author":"D Khanna","year":"2013","unstructured":"Khanna D, Gladue H, Channick R, Chung L, Distler O, Furst DE, Hachulla E, Humbert M, Langleben D, Mathai SC, Saggar R, Visovatti S, Altorok N, Townsend W, FitzGerald J, McLaughlin VV: Recommendations for screening and detection of connective tissue disease-associated pulmonary arterial hypertension. Arthritis Rheum. 2013, 65: 3194-3201. 10.1002\/art.38172.","journal-title":"Arthritis Rheum"},{"key":"493_CR11","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","volume":"73","author":"JG Coghlan","year":"2013","unstructured":"Coghlan JG, Denton CP, Grunig E, Bonderman D, Distler O, Khanna D, Muller-Ladner U, Pope JE, Vonk MC, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenberg DM, McLaughlin VV, Seibold JR: Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2013, 73: 1340-1349. 10.1136\/annrheumdis-2013-203301.","journal-title":"Ann Rheum Dis"},{"key":"493_CR12","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1183\/09031936.00145608","volume":"34","author":"G Kovacs","year":"2009","unstructured":"Kovacs G, Berghold A, Scheidl S, Olschewski H: Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur Respir J. 2009, 34: 888-894. 10.1183\/09031936.00145608.","journal-title":"Eur Respir J"},{"key":"493_CR13","doi-asserted-by":"publisher","first-page":"D42","DOI":"10.1016\/j.jacc.2013.10.032","volume":"62","author":"MM Hoeper","year":"2013","unstructured":"Hoeper MM, Bogaard HJ, Condliffe R, Frantz R, Khanna D, Kurzyna M, Langleben D, Manes A, Satoh T, Torres F, Wilkins MR, Badesch DB: Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013, 62: D42-D50. 10.1016\/j.jacc.2013.10.032.","journal-title":"J Am Coll Cardiol"},{"key":"493_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/annrheumdis-2011-200546","volume":"71","author":"S Bae","year":"2012","unstructured":"Bae S, Saggar R, Bolster MB, Chung L, Csuka ME, Derk C, Domsic R, Fischer A, Frech T, Goldberg A, Hinchcliff M, Hsu V, Hummers L, Schiopu E, Mayes MD, McLaughlin V, Molitor J, Naz N, Furst DE, Maranian P, Steen V, Khanna D: Baseline characteristics and follow-up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis: results from the PHAROS registry. Ann Rheum Dis. 2012, 71: 1335-1342. 10.1136\/annrheumdis-2011-200546.","journal-title":"Ann Rheum Dis"},{"key":"493_CR15","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/art.37838","volume":"65","author":"CJ Valerio","year":"2013","unstructured":"Valerio CJ, Schreiber BE, Handler CE, Denton CP, Coghlan JG: Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension. Arthritis Rheum. 2013, 65: 1074-1084. 10.1002\/art.37838.","journal-title":"Arthritis Rheum"},{"key":"493_CR16","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/art.1780230510","volume":"23","author":"AT Masi","year":"1980","unstructured":"Masi AT, Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980, 23: 581-590. 10.1002\/art.1780230510.","journal-title":"Arthritis Rheum"},{"key":"493_CR17","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003, 289: 2560-2572. 10.1001\/jama.289.19.2560.","journal-title":"JAMA"},{"key":"493_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ: Recommendations for chamber quantification: a report from the American Society of Echocardiography\u2019s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18: 1440-1463. 10.1016\/j.echo.2005.10.005.","journal-title":"J Am Soc Echocardiogr"},{"key":"493_CR19","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(08)60919-8","volume":"371","author":"N Galie","year":"2008","unstructured":"Galie N, Rubin L, Hoeper M, Jansa P, Al-Hiti H, Meyer G, Chiossi E, Kusic-Pajic A, Simonneau G: Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial. Lancet. 2008, 371: 2093-2100. 10.1016\/S0140-6736(08)60919-8.","journal-title":"Lancet"},{"key":"493_CR20","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1164\/rccm.200904-0563OC","volume":"180","author":"G Kovacs","year":"2009","unstructured":"Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Troster N, Hesse C, Salmhofer W, Graninger W, Gruenig E, Rubin LJ, Olschewski H: Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med. 2009, 180: 881-886. 10.1164\/rccm.200904-0563OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"493_CR21","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.3899\/jrheum.101243","volume":"38","author":"M Hinchcliff","year":"2011","unstructured":"Hinchcliff M, Fischer A, Schiopu E, Steen VD: Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS): baseline characteristics and description of study population. J Rheumatol. 2011, 38: 2172-2179. 10.3899\/jrheum.101243.","journal-title":"J Rheumatol"},{"key":"493_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/acr.20684","volume":"64","author":"SR Johnson","year":"2012","unstructured":"Johnson SR, Fransen J, Khanna D, Baron M, van den Hoogen F, Medsger TA, Peschken CA, Carreira PE, Riemekasten G, Tyndall A, Matucci-Cerinic M, Pope JE: Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken). 2012, 64: 358-367. 10.1002\/acr.20684.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"493_CR23","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1183\/09031936.00042107","volume":"30","author":"T Thenappan","year":"2007","unstructured":"Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M: A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Respir J. 2007, 30: 1103-1110. 10.1183\/09031936.00042107.","journal-title":"Eur Respir J"},{"key":"493_CR24","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3899\/jrheum.130400","volume":"40","author":"H Gladue","year":"2013","unstructured":"Gladue H, Steen V, Allanore Y, Saggar R, Saggar R, Maranian P, Berrocal VJ, Avouac J, Meune C, Trivedi M, Khanna D: Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts. J Rheumatol. 2013, 40: 1706-1711. 10.3899\/jrheum.130400.","journal-title":"J Rheumatol"},{"key":"493_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1536\/ihj.48.523","volume":"48","author":"W Njaman","year":"2007","unstructured":"Njaman W, Iesaki T, Iwama Y, Takasaki Y, Daida H: Serum uric Acid as a prognostic predictor in pulmonary arterial hypertension with connective tissue disease. Int Heart J. 2007, 48: 523-532. 10.1536\/ihj.48.523.","journal-title":"Int Heart J"},{"key":"493_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1183\/09031936.00074312","volume":"41","author":"R Naeije","year":"2013","unstructured":"Naeije R, Vachiery JL, Yerly P, Vanderpool R: The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J. 2013, 41: 217-223. 10.1183\/09031936.00074312.","journal-title":"Eur Respir J"},{"key":"493_CR27","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1161\/CIRCHEARTFAILURE.113.000468","volume":"7","author":"IM Robbins","year":"2014","unstructured":"Robbins IM, Hemnes AR, Pugh ME, Brittain EL, Zhao DX, Piana RN, Fong PP, Newman JH: High prevalence of occult pulmonary venous hypertension revealed by fluid challenge in pulmonary hypertension. Circ Heart Fail. 2014, 7: 116-122. 10.1161\/CIRCHEARTFAILURE.113.000468.","journal-title":"Circ Heart Fail"},{"key":"493_CR28","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1183\/09031936.00091212","volume":"42","author":"BD Fox","year":"2013","unstructured":"Fox BD, Shimony A, Langleben D, Hirsch A, Rudski L, Schlesinger R, Eisenberg MJ, Joyal D, Hudson M, Boutet K, Serban A, Masetto A, Baron M: High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J. 2013, 42: 1083-1091. 10.1183\/09031936.00091212.","journal-title":"Eur Respir J"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0493-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-014-0493-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0493-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-014-0493-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:26:59Z","timestamp":1728923219000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-014-0493-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,10]]},"references-count":28,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,12]]}},"alternative-id":["493"],"URL":"https:\/\/doi.org\/10.1186\/s13075-014-0493-1","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,10]]},"assertion":[{"value":"29 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"493"}}